// App-Quantinova.ai

e22023 : Circulating tumor cells (CTCs) and epithelial mesenchymal transition (EMT) in primary breast cancer.

Researchers

Presenter

  • Marian Karaba

Principal Investigators

  • Michal Mego

  • Gabriel Minarik

  • Paulina Gronesova

  • Eva Oravcova

  • Veronika Svabova

  • Jozef Sufliarsky

  • Juraj Pechan

  • James M. Reuben

  • Jozef Mardiak

  • Juraj Benca

  • Tatiana Sedlackova

  • Denisa Manasova

  • Gabriela Sieberova

  • Zuzana Hlavata

  • Andrej Jurik

  • Tomas Minarik

  • Jan Macuch

Medical Centers

  • Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX

  • nd Oncology Department, Comenius University, Medical School and National Cancer Institute, Bratislava, Slovakia

  • Faculty of Medicine, Comenius University, Bratislava, Slovakia

  • National Cancer Institute, Bratislava, Slovakia

  • Cancer Research Institute, Bratislava, Slovakia.

  • Slovak Medical University in Bratislava, Bratislava, Slovakia

Locations

  • United States

  • Slovakia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Peripheral blood mononuclear cell

  • Circulating tumor cells

  • Cytokeratin 19

  • Snail Family Transcriptional Repressor 1

  • Twist-related protein 1

  • Zinc finger E-box binding homeobox 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A